Your browser doesn't support javascript.
loading
Parenchymal volume analysis to assess longitudinal functional decline following partial nephrectomy.
Munoz-Lopez, Carlos; Lewis, Kieran; Attawettayanon, Worapat; Yasuda, Yosuke; Accioly, João Pedro Emrich; Rathi, Nityam; Lone, Zaeem; Boumitri, Melissa; Campbell, Rebecca A; Wood, Andrew; Kaouk, Jihad; Haber, Georges-Pascal; Eltemamy, Mohamad; Krishnamurthi, Venkatesh; Abouassaly, Robert; Haywood, Samuel; Weight, Christopher; Campbell, Steven C.
Affiliation
  • Munoz-Lopez C; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Lewis K; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Attawettayanon W; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Yasuda Y; Division of Urology, Department of Surgery, Faculty of Medicine, Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand.
  • Accioly JPE; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Rathi N; Tokyo Medical and Dental University, Graduate School, Tokyo, Japan.
  • Lone Z; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Boumitri M; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Campbell RA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Wood A; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Kaouk J; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Haber GP; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Eltemamy M; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Krishnamurthi V; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Abouassaly R; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Haywood S; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Weight C; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Campbell SC; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
BJU Int ; 132(4): 435-443, 2023 10.
Article in En | MEDLINE | ID: mdl-37409822
ABSTRACT

OBJECTIVE:

To identify factors associated with longitudinal ipsilateral functional decline after partial nephrectomy (PN). PATIENTS AND

METHODS:

Of 1140 patients managed with PN (2012-2014), 349 (31%) had imaging/serum creatinine levels pre-PN, 1-12 months post-PN (new baseline), and >3 years later necessary for inclusion. Parenchymal-volume analysis was used to determine split renal function. Patients were grouped as having significant renal comorbidity (CohortSRC diabetes mellitus with insulin-dependence or end-organ damage, refractory hypertension, or severe pre-existing chronic kidney disease) vs not having significant renal comorbidity (CohortNoSRC ) preoperatively. Multivariable regression was used to identify predictors of annual ipsilateral parenchymal atrophy and functional decline relative to new baseline values post-PN, after the kidney had healed.

RESULTS:

The median follow-up was 6.3 years with 87/226/36 patients having cold/warm/zero ischaemia. The median cold/warm ischaemia times were 32/22 min. Overall, the median tumour size was 3.0 cm. The preoperative glomerular filtration rate (GFR) and new baseline GFR (NBGFR) were 81 and 71 mL/min/1.73 m2 , respectively. After establishment of the NBGFR, the median loss of global and ipsilateral function was 0.7 and 0.4 mL/min/1.73 m2 /year, respectively, consistent with the natural ageing process. Overall, the median ipsilateral parenchymal atrophy was 1.2 cm3 /year and accounted for a median of 53% of the annual functional decline. Significant renal comorbidity, age, and warm ischaemia were independently associated with ipsilateral parenchymal atrophy (all P < 0.01). Significant renal comorbidity and ipsilateral parenchymal atrophy were independently associated with annual ipsilateral functional decline (both P < 0.01). Annual median ipsilateral parenchymal atrophy and functional decline were both significantly increased for CohortSRC compared to CohortNoSRC (2.8 vs 0.9 cm3 , P < 0.01 and 0.90 vs 0.30 mL/min/1.73 m2 /year, P < 0.01, respectively).

CONCLUSIONS:

Longitudinal renal function following PN generally follows the normal ageing process. Significant renal comorbidities, age, warm ischaemia, and ipsilateral parenchymal atrophy were the most important predictors of ipsilateral functional decline following establishment of NBGFR.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: United States